Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:27 PM
Ignite Modification Date: 2025-12-25 @ 1:43 PM
NCT ID: NCT01757392
Description: None
Frequency Threshold: 5
Time Frame: All Post Dose visits over approximately 9 months, including treatment phase (5 months) and follow up period (4 months)
Study: NCT01757392
Study Brief: Candin Safety & Efficacy Study for the Treatment of Warts
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
CandinĀ® 0.3 mL Monthly intralesional injections of Candida albicans Skin Test Antigen 0.3 ml until lesion resolves or up to 6 injections. 0 None 1 35 34 35 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cholecystitis NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA V17.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site erythema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Injection site Pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Injection site swelling NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Injection site pruritus NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.0) View
Fatigue NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Injection site exfoliation NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Influenza like illness NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Diarrhea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.0) View
Injection site vesicles NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.0) View
Wheezing NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (17.0) View
Sinusitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.0) View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.0) View
Alanine aminotranferase increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.0) View